Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy

MLA

Hjorth, Olof, et al. Serotonin and Dopamine Transporter Availability in Social Anxiety Disorder after Combined Treatment with Escitalopram and Cognitive-Behavioral Therapy. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1349348106&authtype=sso&custid=ns315887.

APA

Hjorth, O., Frick, A., Gingnell, M., Engman, J., Björkstrand, J., Faria, V., Alaie, I., Carlbring, P., Andersson, G., Jonasson, M., Lubberink, M., Antoni, G., Reis, M., Wahlstedt, K., Fredrikson, M., & Furmark, T. (2022). Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy.

Chicago

Hjorth, Olof, Andreas Frick, Malin Gingnell, Jonas Engman, Johannes Björkstrand, Vanda Faria, Iman Alaie, et al. 2022. “Serotonin and Dopamine Transporter Availability in Social Anxiety Disorder after Combined Treatment with Escitalopram and Cognitive-Behavioral Therapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1349348106&authtype=sso&custid=ns315887.